Professor, Medicine, University of California San Diego School of Medicine
Internal Medicine
Dr. Richard H. Haubrich, MD
|
|
Give Review
Richard Haubrich works in the field of Internal Medicine. He went to medical school at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31 in research and 72 in primary care medicine He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Richard H. Haubrich, MD is a published MD as well. He has 28 publications published. The latest was: Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men. Richard H. Haubrich accepts Medicare.
Publications
- Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men.
- Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
- Changes in metabolic syndrome status after initiation of antiretroviral therapy.
- Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Inte...
- Antiretroviral therapy in the elite controller: justified or premature?
- Community HIV-1 drug resistance is associated with transmitted drug resistance.
- Antiretroviral Therapy and Efficacy after Virologic Failure on First-line Boosted Protease Inhibitor Regimens.
- Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.
- Cytomegalovirus Replication in Semen is Associated with Higher Levels of Proviral HIV DNA and CD4+ T cell Activation during Antiretroviral Treatment.
- HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients Successfully Treated With Antiretroviral Therapy.
- Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART.
- Randomized Trial of CNS-Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder.
- Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis.
- An intervention study examining the effects of condom wrapper graphics and scent on condom use in the Botswana Defence Force.
- Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation.
- Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherence.
- Virologic Correlates of Anti-CMV IgG Levels in HIV-1 Infected Men.
- Condom use behaviors and correlates of use in the Botswana Defence Force.
- Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1 infected men who have sex with men.
- Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1.
- Characterizing HIV transmission networks across the United States.
- Economic Modeling of the Combined Effects of HIV-Disease, Cholesterol and Lipoatrophy Based on ACTG 5142 Trial Data.
- Transmitted Drug Resistance in the CFAR Network of Integrated Clinical Systems Cohort: Prevalence and Effects on Pre-Therapy CD4 and Viral Load.
- Defining treatment failure in resource-rich settings.
- Resistance and replication capacity assays: clinical utility and interpretation.
- Will Risk Compensation Accompany Pre-Exposure Prophylaxis for HIV?
- Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142.
Schools
University of Southern California Keck School of Medicine
Mercy Hospital
University Mass Med Center
Doctors Specialties
- Infectious Disease Medicine
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Massachusetts -
Scripps Mercy Hospital -
Keck School of Medicine of USC
Hospital
-
UC San Diego Health
Drug Facts
| NPI NUMBER | 1326063496 | |
| NPPES Provider LastName | HAUBRICH | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 921039001 | |
| NPPES Provider State | CA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 366.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326063496 |
| Last Name Of The Provider | HAUBRICH |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Brent C. Drouin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shawn Harrity, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert J. Carpenter, DO |
|
|
Dr. Arvin Saluta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon D. Harrison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip C. Paik, MD |
|
|
Dr. Shira Abeles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Constance A. Benson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Myres W. Tilghman II, MD
This Doctor is OpenDoctor Recommended.
|